FactBio Release: New Bioinformatics Company Launched

FactBio To Develop New Products for Knowledge Management

Cambridge, 2 December 2015… FactBio, a developer of novel bioinformatics software with a focus on improving knowledge management and data sharing, has been established.

FactBio has been established to develop novel bioinformatics software to improve life sciences research. In particular the company will focus on the development of Kusp (Knowledge Sharing Platform), a knowledge management system which will allow researchers to select a series of BioBuckets and use these to track entities of interest to them, and receive updates of new developments. The entities could include genes, pathways, proteins, or even people and publications as required. Kusp will also be fully integrated into social media, allowing researchers to share their discoveries with the global community.

Users of Kusp will be able to use a number of BioBuckets to track entities of interest for free, but for users who want to keep abreast of a wider range there will be an additional charge. Packages will also be available for enterprise users.

Alongside, Kusp, which will be launched in early 2016, FactBio has plans to develop a range of additional bioinformatics software products. In addition, FactBio is working with a number of life science companies on a consultancy basis and is running a series of training events for bioinformaticians.

Dr James Malone, CEO of FactBio said: “With the increasing amount of data now available to researchers, there is a need for new and improved ways to monitor an increasing range of interests. Through Kusp, researchers can automate keeping track of their many interests, whether they are individual genes, pathways, drugs, research papers or even people. In addition, FactBio will also be developing advanced analysis software, drawing on our machine learning background.”

The company has been established by Dr James Malone, an experienced bioinformatician who will become CEO, and Tony Stephenson as Chief Operating Officer, alongside Simon Jupp as Technology Consultant.

Dr Malone and Mr Jupp have particular experience in projects such as Centre for Therapeutic Target Validation, EBI Linked Data Platform, Orphanet Rare Disease, and Experimental Factor Ontology.

MORE ON THIS TOPIC